# Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease

> **NCT03664830** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 5 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Plerixafor

## Key facts

- **NCT ID:** NCT03664830
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-09-19
- **Primary completion:** 2026-08-03
- **Final completion:** 2026-08-03
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03664830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03664830, "Safety of Blood Stem Cell Mobilization With Plerixafor in Patients With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03664830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*